Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
START Midwest
Grand Rapids, Michigan, USA
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
01
Overview
START Midwest specializes in early phase (Primarily Phase I) oncology clinical trials as a core site within the START Center's global network, contributing to the first-in-human trials of novel anticancer therapeutics, with involvement in trials that have led to dozens of FDA/EMA-approved therapies[5][2][1][3].
- Therapeutic areas
- Oncology
- Modalities
- Small moleculeMonoclonal antibodyAntibody-drug conjugatemRNA-based drugsBiologicGene therapy
- Industry
- Contract Research Organization
02
Partnerships
Cancer and Hematology Centers (CHC)Biopharma sponsorsContract Research Organizations (CROs)
Beyond the preview
Go deeper on START Midwest.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on START Midwest.